Isorhamnetin as a novel inhibitor of pneumolysin against Streptococcus pneumoniae infection in vivo/in vitro
Microbial Pathogenesis · 2023
DOI: 10.1016/j.micpath.2023.106382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2023. Verfasst von Yinuo Zou und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Zoonotic Diseases, Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary …. Hauptthemen laut MEDLINE: Pneumococcal Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The increasing incidence of Streptococcus pneumoniae (S. pneumoniae) infection severely threatened the global public heath, causing a significant fatality in immunocompromised hosts. Notably, pneumolysin (PLY) as a pore-forming cytolysin plays a crucial role in the pathogenesis of pneumococcal pneumonia and lung injury. In this study, a natural flavonoid isorhamnetin was identified as a PLY inhibition to suppress PLY-induced hemolysis by engaging the predicted residues and attenuate cytolysin PLY-mediated A549 cells injury. Underlying mechanisms revealed that PLY inhibitor isorhamnetin further contributed to decrease the formation of bacterial biofilms without affecting the expression of PLY. In vivo S. pneumoniae infection confirmed that the pathological injury of lung tissue evoked by S. pneumoniae was ameliorated by isorhamnetin treatment. Collectively, these results presented that isorhamnetin could inhibit the biological activity of PLY, thus reducing the pathogenicity of S. pneumoniae. In summary, our study laid a foundation for the feasible anti-virulence strategy targeting PLY, and provided a promising PLY inhibitor for the treatment of S. pneumoniae infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Zoonotic Diseases, Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun, China.
- College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
- State Key Laboratory for Zoonotic Diseases, Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun, China. Electronic address: dyh@…
- The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Nei Monggol, China. Electronic address: chilanfu333@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zou, Y., Wang, H., Fang, J., Sun, H., Deng, X., Wang, J., Deng, Y., & Chi, G. (2023). Isorhamnetin as a novel inhibitor of pneumolysin against Streptococcus pneumoniae infection in vivo/in vitro. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2023.106382
Vancouver
Zou Y, Wang H, Fang J, Sun H, Deng X, Wang J, et al. Isorhamnetin as a novel inhibitor of pneumolysin against Streptococcus pneumoniae infection in vivo/in vitro. Microbial Pathogenesis. 2023. doi:10.1016/j.micpath.2023.106382
BibTeX
@article{Zou2023,
author = {Zou, Yinuo and Wang, Haiting and Fang, Juan and Sun, Hongxiang and Deng, Xuming and Wang, Jianfeng and Deng, Yanhong and Chi, Gefu},
title = {Isorhamnetin as a novel inhibitor of pneumolysin against Streptococcus pneumoniae infection in vivo/in vitro},
journal = {Microbial Pathogenesis},
year = {2023},
doi = {10.1016/j.micpath.2023.106382}
}
EUVIMED